Latest Share Chat

IN BRIEF: Genedrive receives Indian import license for Covid test kit

Fri, 25th Jun 2021 14:39

Genedrive PLC - Manchester, England-based molecular diagnostics firm - Confirms it has received license to import its SARS-CoV-2 kit into India via its partner DIVOC Health. Genedrive received approval from the Indian Council of Medical Research for its Covid testing kit back in April.

Genedrive's 96 SARS-CoV-2 Kit is designed to detect active infection in Covid patients and eliminates the need for cold temperature storage, making it ideal for high temperature countries such as India.

Current stock price: 55.87 pence, up 13% on Friday

Year-to-date change: up 15%

By Will Paige; willpaige@alliancenews.com

Related Shares

More News

10 May 2024 12:10

IN BRIEF: Genedrive completes placing portion of GBP6 million raise

Genedrive PLC - Manchester-based pharmacogenetic testing - Completes placing of 138.8 million new shares at 1.5 pence each, raising GBP2.1 million. Th...

10 May 2024 10:59

AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

10 May 2024 07:00

IN BRIEF: Genedrive aims to raise at least GBP6 million in share offer

Genedrive PLC - Manchester-based pharmacogenetic testing company - Seeks to raise a minimum of GBP6.0 million from an offer of new shares at 1.5 pence...

24 Apr 2024 17:26

Genedrive enters clinical trial deal in US for MT-RNR1 US approval

(Alliance News) - Genedrive PLC on Wednesday said it has entered into a clinical trial agreement to support clinical studies to progress the regulator...

3 Apr 2024 16:54

LONDON MARKET CLOSE: FTSE 100 up thanks to US economic data

(Alliance News) - Stock prices in London closed mostly higher on Wednesday, after some data from the US reinforced the interest rate cut trajectory ac...